Industry Academia Alliances


Asia/Qatar Industry Academia Alliances Save the date Hilton Hotel Doha Research doj2006@qatar-med.cornell.edu AT Hilton Hotel Doha

Thomas Caskey, MD, FACP, FRSC

Thomas Caskey
Professor of Molecular and Human Genetics
Baylor College of Medicine
Houston, TX, USA

Dr. C. Thomas Caskey has over 35 years of experience in molecular genetics. Currently serves as Professor of Molecular and Human Genetics at Baylor College of Medicine.

Dr. Caskey was the CEO of The Brown Foundation Institute of Molecular Medicine at UTHSC-Houston. Dr. Caskey served as Senior VP, Human Genetics and Vaccines Discovery at Merck Research Laboratories, West Point, and as President of the Merck Genome Research Institute.

Dr. Caskey is Board Certified in Internal Medicine, Medical Genetics, and Molecular Genetics with 25 years of patient care experience. Member of: National Academy of Sciences, Institute of Medicine (Chair, Board on Health Sciences Policy), Royal Society of Canada, past President: American Society of Human Genetics & Human Genome Organization, and Texas Academy of Medicine, Engineering and Science. He is an editor of the Annual Reviews of Medicine.

Dr. Caskey received numerous academic and industry honors. His genetic research identified genetic basis of 15 major inheritable diseases and clarified the understanding of “anticipation” in triplet repeat diseases (Fragile X, myotonic dystrophy and over 30 others). His personal identification patent is the basis of worldwide application for forensic science and he is also a consultant to the FBI in forensic science. He is currently directing a program of Precision Medicine with Young Presidents Organization (YPO) co-sponsored by The Cullen Foundation for Higher Education. The program won the YPO International Award for most innovative education program. He is a Consultant to Human Longevity, Inc. and a member of the Board of Metabolon, Inc., both, leaders in precision medicine technology. His current research focuses on the application of whole genome sequence and metabolomics of individuals toward the objective of disease risk and its prevention.